CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2016		Dec. 31, 2015
CURRENT ASSETS
Cash and cash equivalents	$ 22,088		$ 42,229
Available for sale securities	627		753
Trade accounts and grants receivable, net	446		1,078
Landlord receivable	200		567
Receivable from affiliates	511		0
Prepaid expenses and other current assets	1,777		2,610
Total current assets	25,649		47,237
Property, plant and equipment, net	5,529	[1]	7,539
Deferred license fees	118		322
Deposits and other long-term assets	1,031		1,299
Equity method investment in Asterias, at fair value (Note 4)	100,039		0
Equity method investment in Ascendance	0		4,671
Intangible assets, net	10,206	[2]	33,592
TOTAL ASSETS	142,572		94,660
CURRENT LIABILITIES
Accounts payable and accrued liabilities	7,144	[3]	9,377
Capital lease liability, current portion	202		38
Promissory notes, current portion	99		95
Related party convertible debt	833		0
Deferred grant income	0		2,513
Deferred license and subscription revenue, current portion	572		439
Total current liabilities	8,850		12,462
LONG-TERM LIABILITIES
Deferred revenues, net of current portion	308		615
Deferred rent liabilities, net of current portion	50		158
Lease liability	1,386		4,400
Capital lease liability, net of current portion	310		26
Related party convertible debt, net of discount	1,032		324
Promissory notes, net of current portion	120		220
Other long term liabilities	8		8
TOTAL LIABILITIES	12,064		18,213
Commitments and contingencies (Note 11)
SHAREHOLDERS' EQUITY
Series A convertible preferred stock, no par value, authorized 2,000 shares as of December 31, 2016 and 2015; none issued and outstanding as of December 31, 2016 and 2015, respectively	0		0
Common stock, no par value, authorized 150,000 shares; issued and outstanding shares; 103,396 shares issued and 102,776 outstanding as of December 31, 2016 and 94,894 issued and 90,421 outstanding as of December 31, 2015	317,878		273,979
Accumulated other comprehensive loss	(738)		(237)
Accumulated deficit	(196,321)		(229,893)
Treasury stock at cost: 620 and 4,473 shares at December 31, 2016 and 2015, respectively	(2,891)		(18,033)
BioTime, Inc. shareholders' equity	117,928		25,816
Noncontrolling interest	12,580		50,631
Total shareholders' equity	130,508		76,447
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	$ 142,572		$ 94,660

[1] (1) Reflects the effect of the Asterias Deconsolidation.

[2] Reflects the effect of the Deconsolidation.

[3] Reflects the effect of the Asterias Deconsolidation.